Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #754073 on NorthWest Biotherapeutics Inc (NWBO)
DrHigh
03/13/25 5:10 PM
#754084 RE: KRISGO #754073
Advent Bio revenue up 23% between 2022 and 2023, as filed on March 4, 2025.💪Revenue is likely from the UK Specials Programme to produce DCVax-L. Can't wait to see the 2024 numbers, as they will likely be significant.👍$nwbo #dcvax #glioblastoma #gbmhttps://t.co/NuVrs47Bse pic.twitter.com/a1FsLAgGnr— rj (@sharpie510) March 4, 2025
Advent Bio revenue up 23% between 2022 and 2023, as filed on March 4, 2025.💪Revenue is likely from the UK Specials Programme to produce DCVax-L. Can't wait to see the 2024 numbers, as they will likely be significant.👍$nwbo #dcvax #glioblastoma #gbmhttps://t.co/NuVrs47Bse pic.twitter.com/a1FsLAgGnr
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads